Purpose: To evaluate the efficacy and safety of intrasilicone injection of bevacizumab for the treatment of iris neovascularization after vitrectomy for proliferative diabetic retinopathy.
Methods: Bevacizumab 1.25 mg/0.05 ml was injected into silicone oil in 15 eyes of 11 patients with iris neovascularization which had developed 2.5-6 months after vitrectomy and silicone oil tamponade. The main outcome measures were regression of iris neovascularization, intraocular pressure elevation, and visual acuity.
Results: In all eyes, iris neovascularization regressed and postinjection intraocular pressure was controlled within 7 days postinjection. Visual acuity improved in 12 eyes. In 4 patients, iris neovascularization recurred within 10 weeks after the injection and they were successfully treated with a second intrasilicone bevacizumab injection of the same dose.
Conclusion: Intrasilicone injection of bevacizumab is safe and effective in the treatment of patients with iris neovascularization after vitrectomy for advanced proliferative diabetic retinopathy. Further studies on greater numbers of patients and more advanced neovascularization are recommended.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000341734 | DOI Listing |
Cureus
December 2024
Radiology Department, King Khaled Eye Specialist Hospital, Riyadh, SAU.
Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic multisystem phakomatosis that can affect the skin, bones, and nervous system. NF1 typically presents with skin lesions, including freckles, café-au-lait macules, plexiform neurofibromas, and bony dysplasia, and is usually accompanied by a family history of the disorder. Ocular manifestations vary, but iris Lisch nodules and optic nerve gliomas are the most common features.
View Article and Find Full Text PDFJ Vitreoretin Dis
August 2024
University Hospitals Eye Institute, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
To present a case of acute B-cell lymphoblastic leukemia (B-ALL) ocular relapse treated with chimeric antigen receptor T-cell (CAR T) therapy. A retrospective case review was evaluated. A 69-year-old woman with a history of BALL presented with bilateral hypopyons and 3+ anterior chamber cells that responded to topical prednisolone.
View Article and Find Full Text PDFBMJ Case Rep
November 2024
Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester, UK.
To our knowledge, this is the first report of anterior segment ischaemia after PreserFlo Micro-Shunt insertion surgery. Our patient developed anterior chamber (AC) activity and keratic precipitates 1 week after surgery. Five weeks after surgery, examination revealed a shallow AC, a distorted pupil with posterior synechiae and surface iris neovascularisation.
View Article and Find Full Text PDFAm J Ophthalmol
October 2024
From the Moorfields Eye Hospital NHS Foundation Trust (R.A., P.S., N.S., S.A., A.R., J.R., S.S., L.W.), London, UK.
Rom J Ophthalmol
October 2024
Head Vitreoretina and Uvea Services, Post Graduate Department of Ophthalmology, Command Hospital Air Force Agaram Post Bangalore, India.
Introduction: Neovascularization of the lens is a rare entity linked to lens-induced inflammation due to many causes like trauma. We describe a case managed using suprachoroidal triamcinolone, an anti-VEGF injection, in conjunction with cataract surgery and IOL implantation.
Patient And Clinical Findings: A male patient, 27, presented with a severe reduction in vision in his right eye (RE) accompanied by redness for one month.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!